ArticleDeutsches Arzteblatt international2021
Years of Life Lost to Death—A Comprehensive Analysis of Mortality in Germany Conducted as Part of the BURDEN 2020 Project
Article in Deutsches Arzteblatt international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.
- The burden of premature mortality from cardiovascular diseases: A systematic review of years of life lost.PloS one · 2023Pooled it
- Years of Life Lost of Patients With Early Adenocarcinoma of the Esophagogastric Junction Compared to Esophageal or Gastric Adenocarcinoma. A Registry-Based Study.Cancer medicine · 2026Article
- Estimating years of life lost due to premature mortality at regional level in France in 2017, using a probabilistic redistribution approach.BMC public health · 2025Article
- Temporal trends in mortality due to coronary heart disease in Germany from 1998 to 2023.Journal of health monitoring · 2025Article
- Parkinson disease - Prevalence, trends and regional patterns in Germany. An analysis based on routine data from the statutory health insurance.Journal of health monitoring · 2025Article
- Mortality from prostate cancer in the years 2007-2021 in North Rhine-Westphalia, Germany.BMC urology · 2024Article
- Premature mortality for patients after completely resected early adenocarcinoma of the esophagus or stomach.Cancer medicine · 2024Article
- The mortality burden related to COVID-19 in 2020 and 2021 - years of life lost and excess mortality in 13 countries and sub-national regions in Southern and Eastern Europe, and Central Asia.Frontiers in public health · 2024Article
- Widening area-based socioeconomic inequalities in cancer mortality in Germany between 2003 and 2019.Scientific reports · 2023Article
- Assessment of the Potential of Concentrating Cancer Care in Hospitals With Certification Through Survival Analysis.Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) · 2023Article
- Personalized Treatment for Patients With Lung Cancer.Deutsches Arzteblatt international · 2023Review
- Spatio-Temporal Trends in the Incidence of Type 2 Diabetes in Germany.Deutsches Arzteblatt international · 2023Article
- Article
- Article
- Optimizing the cancer research landscape for the benefit of patients and society: A strategic perspective of the German Cancer Research Center (DKFZ) and its partnerships with university medical centers.Cancer biology & medicine · 2022Article
- German Index of Socioeconomic Deprivation (GISD): Revision, update and applications.Journal of health monitoring · 2022Article
- The Burden of Disease in Germany at the National and Regional Level—Results in Terms of Disability-Adjusted Life Years (DALY) from the BURDEN 2020 Study.Deutsches Arzteblatt international · 2022Article
- Framework and baseline examination of the German National Cohort (NAKO).European journal of epidemiology · 2022Article
- Is Covid-19 a dread risk? The death toll of the pandemic year 2020 in long-term and transnational perspective.Futures · 2022Article
- Time Trends and Income Inequalities in Cancer Incidence and Cancer-Free Life Expectancy - a Cancer Site-Specific Analysis of German Health Insurance Data.Frontiers in oncology · 2022Article
Corrections and comments
- Commented on by
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKnowing which diseases and causes of death account for most of the years of life lost (YLL) can help to better target appropriate prevention and intervention measures. The YLL in Germany for specific causes of death were estimated as part of the BURDEN 2020 project at the Robert Koch Institute.
methodsData from cause-of-death statistics were used for the analysis. ICD codes were grouped into causes of death categories at different levels of disaggregation. The YLL were estimated by combining each cause of death with the remaining life expectancy at the age of death. Deaths and YLL were compared by sex, age category, and regional distribution.
resultsApproximately 11.6 million years were estimated to be lost in Germany in 2017, of which 42.8% were lost by women and 57.2% by men. The largest number of YLL were due to (malignant) neoplasms (35.2%), followed by cardiovascular diseases (27.6%), gastrointestinal diseases (5.8%), and neurological diseases (5.7%). Deaths at younger ages had a greater impact on population health if expressed in YLL: the death share of persons under age 65 was 14.7%, but the years of life lost in this age group amounted to 38.3% of all YLL. The most common causes of death in this group include accidents, self-injury and violence, malignant neoplasms, and alcohol-related diseases.
conclusionA large proportion of YLL is borne by young and middle-aged persons. These findings emphasize the need to introduce preventive strategies early in life to reduce the YLL at younger ages, as well as to prevent risk factors for diseases in older ages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.